Wednesday, May 25, 2011

Anacor Pharmaceuticals Announces Retirement of Zhi Hong from Board of Directors - MarketWatch

Anacor Pharmaceuticals Announces Retirement of Zhi Hong from Board of Directors MarketWatch In addition, Anacor is nonindustrial AN2718 as type A topical antifungal wares candidate for the treatment of onychomycosis and skin plant infections, and AN2898 as a topical anti-inflammatory product nominee for the attention of psoriasis and atopic ... and more » Link To Article

No comments:

Post a Comment